A. De Léan - Concepedia

Author

A. De Léan

Montreal Clinical Research Institute

Also Known As

A De Lean, A De Léan, A de Léan, A. DE LEAN, A. DE LÉAN,, A. De Lean, A. De Léan, A. De LÉAN, A. De Léan, A. de Lean

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Montreal Clinical Research Institute Université de Montréal Inserm Université de Rouen Normandie Duke Medical Center

About

A. De Léan is an author at Montreal Clinical Research Institute specializing in medicine, physiology, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	39	4.7K
2	Natural Sciences	4	4	440
3	Public Health	3	3	128
4	Social Sciences	2	2	59
5	Health Sciences	1	1	10

A. De Léan

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. A. De Léan, Jeffrey M. Stadel, Robert J. Lefkowitz Journal of Biological Chemistry Agonist-specific Binding PropertiesExperimental PharmacologyTernary Complex HrxMolecular PharmacologyTernary Complex Model	1980	1.6K
Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. A. De Léan, Arthur A. Hancock, Robert J. Lefkowitz Molecular Pharmacology Drug TargetRadioligand Binding DataMedicineQuantitative AnalysisRational Drug Design	1982	594
Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. Jacques Drouin, Yu Sun, Michel Chamberland, The EMBO Journal Molecular PhysiologyEndocrine MechanismMedicineGeneticsHormonal Receptor	1993	325
Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. David R. Sibley, A. De Léan, Ian Creese Journal of Biological Chemistry NeurotransmitterPharmacotherapyMedicinal ChemistryNeuroendocrine MechanismHomogeneous Affinity	1982	295
Modulation of Pituitary Thyrotropin Releasing Hormone Receptor Levels by Estrogens and Thyroid Hormones A. De Léan, Louise Ferland, Jacques Drouin, Endocrinology Pituitary GlandEndocrine MechanismMedicinePituitary Trh ReceptorsPhysiology	1977	227
Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa A. De Léan, Jolanta Gutkowska, Normand McNicoll, Life Sciences Adrenal GlandSodium HomeostasisMedicinePhysiologySpecific Receptors	1984	191
Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists. A. De Léan, Brian F. Kilpatrick, M G Caron Molecular Pharmacology Dopamine ReceptorPituitary GlandMedicinePhysiologyNeuroendocrine Mechanism	1982	161
The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland. K A Wreggett, A. De Léan Molecular Pharmacology	1984	151
Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Ernst Bürgisser, A. De Léan, Robert J. Lefkowitz Proceedings of the National Academy of Sciences NeurotransmitterPharmacotherapyMolecular PharmacologyReciprocal ModulationAntagonist Binding	1982	132
Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor. Jacques Drouin, Yuchu Sun, Samuel Tremblay, Molecular Endocrinology Receptor Homodimer FormationDna AnalysisMolecular BiologyGlucocorticoid ReceptorTranscriptional Regulation	1992	120

Page 1